Activity
Today Sanitas Group has modern development and manufacturing facilities in Lithuania, Slovakia and Poland. They produce a variety of medicines in different formulations including tablets, capsules, injectables, sterile powders and semi solids.
The Group has broad portfolio in the generics sector with about 129 products on the market, in addition to over 30 products in the development pipeline and in registration, enabling the it to provide customers with a wide range of affordable high quality pharmaceuticals.
Sanitas group holds the position of leadership in the Baltics. Current areas of focus are new growth generic markets such as Russia, Slovakia and Poland. Future area of focus are South East Europe.